Ascendis Pharma A/S ADR (NASDAQ: ASND): Reassessing Prospects
Ascendis Pharma A/S ADR (ASND) concluded trading on Thursday at a closing price of $113.81, with 2.27 million shares of worth about $258.78 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -26.08% during that period and on September 12, 2024 the price saw […]
